Log in to save to my catalogue

Amyloid-[beta] peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Amyloid-[beta] peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A602357139

Amyloid-[beta] peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

About this item

Full title

Amyloid-[beta] peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Publisher

BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2019-10, Vol.11 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background One of the major challenges in diagnosing dementia with Lewy bodies (DLB) is the common co-morbid presence of amyloid pathology. To understand the putative role of altered amyloid-[beta] (A[beta]) metabolism in dementia with DLB, we analyzed levels of different cerebrospinal fluid (CSF) A[beta] peptides (A[beta]38, A[beta]40, A[beta]42)...

Alternative Titles

Full title

Amyloid-[beta] peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracacademiconefile_A602357139

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A602357139

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-019-0537-5

How to access this item